Your browser doesn't support javascript.
loading
Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma.
Villano, Anthony M; O'Halloran, Eileen; Goel, Neha; Ruth, Karen; Barrak, Dany; Lefton, Max; Reddy, Sanjay S.
Affiliation
  • Villano AM; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • O'Halloran E; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Goel N; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Ruth K; Department of Biostatistics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Barrak D; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Lefton M; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Reddy SS; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
J Surg Oncol ; 126(3): 502-512, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35476892
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Carcinoma, Pancreatic Ductal Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Surg Oncol Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Carcinoma, Pancreatic Ductal Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Surg Oncol Year: 2022 Type: Article Affiliation country: United States